Philippe Tramoy

🎯 Our Mission: Kapsera pioneers cutting-edge natural formulations that empower sustainable agriculture, enrich human nutrition, and improve animal health through innovative biosolutions and feed additives. 🚀Our ambition : We bridge the gap between sustainability and productivity in agriculture by upgrading biofertilizers and biopesticides with cutting-edge formulation technologies.

As fast-spreading viral diseases are a constant threat to the livestock industry, ViroVet’s team of researchers and unique network of academic and industrial partners will deliver products to reduce the impact of these diseases by providing innovative virus control solutions to secure and improve the health and value of livestock.

Livestock disease prevention and sustainable agri productivity. Singaporean synbio startup funded by EF Venture Capital.

Animab is a new venture designed to address the changing needs of animal production. Using proprietary research discoveries, Animab targets the emerging science and new possibilities in the gut. The interdisciplinary team integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies and sustainability. Led by an experienced group of experts with expertise in a range of relevant domains from vaccines, biotechnology, business management and international marketing, Animab is dedicated to offering a safe and sustainable way to ensure animal performance. More information: www.animab.com.

DIABNEXT was founded with the vision of developing highly innovative solutions that help people with diabetes better manage their chronic condition and improve their care and quality of life. Through collaboration with many leaders and clinicians in diabetes healthcare, the DIABNEXT platform offers patients a unique solution that enables remote monitoring, coordination, therapeutic education and analytics of data related to blood glucose, insulin, diet and physical activity automatically through connected health devices. DIABNEXT was acquired by Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, in March 2022. The DIABNEXT platform is now marketed under the name Glooko XT.

La plateforme de myBrain Tech aide les industries à simplifier l'interprétation de la dynamique du cerveau et à extraire des informations instructives pour mieux comprendre l'impact de leur produit ou service sur le cerveau de leurs utilisateurs. Notre équipe de neuroscientifiques et de data scientists développe des algorithmes et des tableaux de bord automatisés pour analyser et interpréter les données EEG et comportementales des humains dans un contexte réel, et créer un modèle d'IA stratégique. myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics and to extract informative insight to better understand the impact of their product or services on their users's brains. Our team of neuroscientists and data scientists develops algorithms and automated dashboards to analyse and interpret humans EEG and behavioral data in real life context, and create strategic AI Model.

Scipio Bioscience, a Paris-based biotechnology company, provides novel sample preparation solutions for single-cell studies in the form of easy-to-use benchtop kits and intuitive, cloud-based software. Scipio Bioscience exploits a proprietary technology for barcoding for preparation of samples for single-cell profiling. The initial target of Scipio Bioscience is to provide sample preparation for single-cell transcriptomics freed of the substantial investment and running costs of existing technologies, while attaining the flexibility and scalability required in state-of-the-art research. The blooming applications in single-cell transcriptomics have revealed the importance of characterizing the diversity of cell profiles in normal tissues and cancerous tumors. For optimal results, numbers of cells in the range of thousands must be analyzed simultaneously by RNA-sequencing procedures. The costs and constraints of available methods for sample preparation have hampered widespread adoption of this approach. Scipio Bioscience overcomes these obstacles by providing a test-tube solution readily accessible to laboratories in all fields of biological research. The first outcome of this technology was the commercial release of the Asteria™ Single-cell RNA-seq Kit and its companion data analysis software Cytonaut™ in May 2022. Able to analyze 10,000 input cells in a single-tube, the kit bypasses the use of microfluidics or plate in favor of a simple, accessible protocol that is easier on cells and enables a stable stopping point 2 hours in. The resulting sequencing data can be analyzed with Cytonaut™, a cloud-based software that covers the entire 3’ scRNA-seq data analysis chain and emphasizes on the ease-of-use for biologists and bioinformaticians alike. Scipio bioscience is housed in the Paris Santé Cochin incubator, located in the celebrated Parisian Cochin Hospital.

Created in 2013, CryoCapCell® designs, develops and globally markets the CryoCapsule®: a unique, proprietary technology for high-pressure vitrification. CryoCapCell constantly innovates to make your Correlative Light and Electron Microscopy experiments faster, simpler and more reliable. Thanks to the highly innovative nature of its technologies, CryoCapCell has developed partnerships with leading scientific research institutions, including Institut Curie and the Mechanical and Materials Engineering Laboratory (PIMM) at Arts et Métiers. www.cryocapcell.com

Keen Eye is the AI platform company that elevates computational pathology to guide better drug development and diagnostics. *** Keen Eye has recently been acquired by Tribun Health*** Tribun Health powers the digital transformation of cancer diagnosis by designing innovative AI-based solutions to enable the management, analysis and sharing of pathology images for diagnostic labs, pharmaceutical and CRO companies. Please also check the Tribun Health website: https://www.tribun.health/

Harnessing its millifluidic technologies, MilliDrop develops and markets systems for microbiology applications that incubate, analyze and handle thousands of hundred-nanoliter-scale samples in parallel. Given the Analyzer’s compact nature, the effectiveness of dropletbased cultivation, and the option of integrating this technology into an automated process, MilliDrop can meet the needs in three segments of the global biological instrument and reagent market : Research, Industrial microbiology & Diagnostic À partir de ses technologies millifluidiques, MilliDrop développe et commercialise des automates pour la microbiologie qui permettent d’incuber, d’analyser et de manipuler des milliers d’échantillons d’une centaine de nanolitres en parallèle. Le caractère compact de l’instrument développé, l’efficacité des cultures à l’échelle de la goutte, et la possibilité d’intégrer cette technologie dans un process d’automates permet à MilliDrop d’adresser trois segments sur le marché global des instruments et réactifs pour la biologie : la Recherche, la Microbiologie Industrielle et le Diagnostic.

HorseCom. A word that is beginning to enter the vocabulary of passionate riders and equine enthusiasts; and we want it to completely change your world view of equestrian. The company’s ambitions are simple: HorseCom is the first wearable device that diffuses music for both horse and rider to create a stronger bond and better synchronization both inside and outside the arena. The device is specially adapted for equine ears and improves the horse’s well-being, enhances performance during training, and aids in recovery. The company is composed of a team of 25 located in the 11th arrondissement of Paris and remote. Created in 2013, HorseCom is a startup specializing in tech innovations for the world of equestrian. After 2 years of scientific research with the help of veterinarians, equine ethologists and industry professionals, riders, trainers, facility owners, engineers, and software developers, HorseCom was developed and brought to market in France in December 2015 and we quickly became France’s leader of innovation in equestrian. HorseCom is preparing for a second round of funding as it begins to launch and expand into the USA and UK markets.

Aenitis Technologies is a spin-off of the Centre National de la Recherche Scientifique (CNRS) and the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH) of the Graduate School of Industrial Physics and Chemistry of the City of Paris (ESPCI) specializing in developing innovative solutions for separation, handling and filtration of biological particles in suspension or not based on acoustophoresis technologies. The company initially focus on medical issues where its technological solutions bring innovation breaks with current practices. The company has many academic and institutional distinctions that promote it as a highly promising French start-up. Aenitis Technologies aims to become a global leader in filtration solutions or fractionation acoustophoresis.

PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.

🎯 Our Mission: Kapsera pioneers cutting-edge natural formulations that empower sustainable agriculture, enrich human nutrition, and improve animal health through innovative biosolutions and feed additives. 🚀Our ambition : We bridge the gap between sustainability and productivity in agriculture by upgrading biofertilizers and biopesticides with cutting-edge formulation technologies.

String’s purpose is to commercialize next generation ingredients that enable sustainability and traceability in evolving value chains. String Bio is in the business of manufacturing raw materials for Animal Nutrition, Agriculture, Human Nutrition and Personal Care sectors that are derived using a sustainable and traceable process. String, as one of the world leaders in gas fermentation, has a strong IP protected platform called SIMP (String Integrated Methane Platform) that enables production of high quality ingredients using methane. Our proprietary platform leverages advances in synthetic biology, fermentation technology, chemistry and process engineering. Our mission is simple: To innovate at the cutting edge of biology, engineering and chemistry to enable sustainable and scalable solutions in sectors that are fundamental to living. - Our impact is in enabling localized manufacturing that provide economically competitive alternatives. - Our impact is in leveraging the carbon in greenhouse gases to build strong value chains. - Our impact is in enabling safe, organic and natural options. - Our impact is in enabling inherent circularity in living.

As fast-spreading viral diseases are a constant threat to the livestock industry, ViroVet’s team of researchers and unique network of academic and industrial partners will deliver products to reduce the impact of these diseases by providing innovative virus control solutions to secure and improve the health and value of livestock.

Livestock disease prevention and sustainable agri productivity. Singaporean synbio startup funded by EF Venture Capital.

Animab is a new venture designed to address the changing needs of animal production. Using proprietary research discoveries, Animab targets the emerging science and new possibilities in the gut. The interdisciplinary team integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies and sustainability. Led by an experienced group of experts with expertise in a range of relevant domains from vaccines, biotechnology, business management and international marketing, Animab is dedicated to offering a safe and sustainable way to ensure animal performance. More information: www.animab.com.